The Evolution of Environmental Disinfection has Taken a Quantum Leap

CASPR Technologies Announces New Product

DALLAS, TEXAS, JUNE 4, 2019—The CASPR Technologies (CASPR) partnered with the Association for Professionals in Infection Control and Epidemiology (APIC) as a Strategic Resource Partner for 2019.

CASPR is exhibiting at the Annual APIC conference held June 12-14 in Philadelphia and will be introducing its new product CASPR Medik™ (pronounced medic) to infection control and epidemiology professionals and the press.

CEO Gail Warrior comments, “As a company that is focused on infection prevention, we are committed to working with healthcare professionals to achieve the common goal of ZERO HAIs. This is just one of the reasons we’ve joined APIC as a Strategic Partner.”

Industry expert John LaRochelle says people can expect to see, “the holy grail in terms of what we’ve been looking for in the industry for cleaning and disinfection to fill the gap between what the housekeepers miss for cleaning and disinfection, and what these enhanced disinfection devices just can’t hit.”

“You couldn’t ask for anything better,” says current customer Lori Townsend, MSN, CIC, CPHQ. “CASPR is continuous disinfection. You don’t have to have the staff involved because it is no-touch. It is completely automated.”

About CASPR Technologies:

CASPR Technologies offers a range of new and unique technologies for a wide array of healthcare services. Our flagship product is the CASPR Medik™, is installed in healthcare settings to naturally reduce the micro-burden on all surfaces.

CASPR began its U.S. operations on October 31, 2016.  Since CASPR has been developing its technology and testing its efficacy against clinically relevant pathogens in an independent laboratory.  The CASPR Medik technology is a continuous 24/7, facility-wide treatment that’s safe to use in occupied healthcare spaces.

CASPR technology has been installed and studied in several hospital trials. Results to date have demonstrated up to an 80% reduction in bacterial and fungal micro-burdens and a significant reduction in the incidence of MRSA and VRE.  Departments being trialed have also experienced a large reduction in employee absenteeism.

“We’ve been able to reduce the level of pathogens between 8 and 10-fold,” says Daniel Marsh, GM of Healthcare for CASPR. “Wouldn’t you want your facility to be 10 times cleaner if you could make that happen?”